CD44 suppresses TLR-mediated inflammation

Journal of Immunology

Volumn 180, Issue 6, 2008, Pages 4235-4245

  Kawana, Hidetada ^a   Karaki, Hirokazu ^a   Higashi, Morihiro ^a   Miyazaki, Masaru ^a   Hilberg, Frank ^b   Kitagawa, Motoo ^a   Harigaya, Kenichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 2; ZYMOSAN; AUTACOID; CD44 PROTEIN, MOUSE; LIGAND; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; DOWN REGULATION; DRUG ANTAGONISM; GENETICS; HOSPITALIZATION; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD44; ARTHRITIS, EXPERIMENTAL; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; ZYMOSAN;

EID: 44849108461     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.6.4235     Document Type: Article

References (39)

1. Jiang, D., J. Liang, J. Fan, S. Yu, S. Chen, Y. Luo, G. D. Prestwich, M. M. Mascarenhas, H. G. Garg, D. A. Quinn, et al. 2005. Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat. Med. 11: 1173-1179.
2. Pure, E., and C. A. Cuff. 2001. A crucial role for CD44 in inflammation. Trends Mol. Med. 7: 213-221.
3. Zeidler, A., R. Brauer, K. Thoss, J. Bahnsen, V. Heinrichs, D. Jablonski-Westrich, M. Wroblewski, S. Rebstock, and A. Hamann. 1995. Therapeutic effects of antibodies against adhesion molecules in murine collagen type II-induced arthritis. Autoimmunity 21: 245-252.
4. Camp, R. L., A. Scheynius, C. Johansson, and E. Pure. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178: 497-507.
5. Brocke, S., C. Piercy, L. Steinman, I. L. Weissman, and T. Veromaa. 1999. Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA 96: 6896-6901.
6. Rafi-Janajreh, A. Q., D. Chen, R. Schmits, T. W. Mak, R. L. Grayson, D. P. Sponenberg, M. Nagarkatti, and P. S. Nagarkatti. 1999. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol. 163: 1619-1627.
7. Wang, X., L. Xu, H. Wang, Y. Zhan, E. Pure, and G. Z. Feuerstein. 2002. CD44 deficiency in mice protects brain from cerebral ischemia injury. J. Neurochem. 83: 1172-1179.
8. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P. M. Henson, and P. W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158.
9. Keystone, E. C., H. U. Schorlemmer, C. Pope, and A. C. Allison. 1977. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 20: 1396-1401.
10. Schorlemmer, H. U., D. Bitter-Suermann, and A. C. Allison. 1977. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology 32: 929-940.
11. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815.
12. Frasnelli, M. E., D. Tarussio, V. Chobaz-Peclat, N. Busso, and A. So. 2005. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res. Ther. 7: R370-R379.
13. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
14. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274: 17406-17409.
15. Protin, U., T. Schweighoffer, W. Jochum, and F. Hilberg. 1999. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J. Immunol. 163: 4917-4923.
16. Ohshima, S., Y. Saeki, T. Mima, M. Sasai, K. Nishioka, S. Nomura, M. Kopf, Y. Katada, T. Tanaka, M. Suemura, and T. Kishimoto. 1998. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95: 8222-8226.
17. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
18. Fujita, Y., M. Kitagawa, S. Nakamura, K. Azuma, G. Ishii, M. Higashi, H. Kishi, T. Hiwasa, K. Koda, N. Nakajima, and K. Harigaya. 2002. CD44 signaling through focal adhesion kinase and its anti-apoptotic effect. FEBS Lett. 528: 101-108.
19. Kitagawa, M., T. Oyama, T. Kawashima, B. Yedvobnick, A. Kumar, K. Matsuno, and K. Harigaya. 2001. A human protein with sequence similarity to Drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters. Mol. Cell. Biol. 21: 4337-4346.
20. Fujita, T., G. P. Nolan, H. C. Liou, M. L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κ B p50 homodimers. Genes Dev. 7: 1354-1363.
21. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17: 677-687.
22. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583-591.
23. Kawana, H., J. Tamaru, T. Tanaka, A. Hirai, Y. Saito, M. Kitagawa, A. Mikata, K. Harigaya, and T. Kuriyama. 1998. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am. J. Pathol. 153: 505-513.
24. Van Meurs, J. B., P. L. van Lent, A. E. Holthuysen, I. I. Singer, E. K. Bayne, and W. B. van den Berg. 1999. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum. 42: 1128-1139.
25. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
26. Ponta, H., L. Sherman, and P. A. Herrlich. 2003. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4: 33-45.
27. Brint, E. K., D. Xu, H. Liu, A. Dunne, A. N. McKenzie, L. A. O'Neill, and F. Y. Liew. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5: 373-379.
28. Beutler, B. 2004. Inferences, questions and possibilities in toll-like receptor signalling. Nature 430: 257-263.
29. Barton, G. M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300: 1524-1525.
30. Entwistle, J., C. L. Hall, and E. A. Turley. 1996. HA receptors: regulators of signalling to the cytoskeleton. J. Cell. Biochem. 61: 569-577.
31. Jiang, H., R. S. Peterson, W. Wang, E. Bartnik, C. B. Knudson, and W. Knudson. 2002. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J. Biol. Chem. 277: 10531-10538.
32. Lesley, J., Q. He, K. Miyake, A. Hamann, R. Hyman, and P. W. Kincade. 1992. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175: 257-266.
33. Van de Loo, F. A., S. Kuiper, F. H. van Enckevort, O. J. Arntz, and W. B. van den Berg. 1997. Interleukin-6 reduces cartilage destruction during experimental arthritis: a study in interleukin-6-deficient mice. Am. J. Pathol. 151: 177-191.
34. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of toll-like receptor signaling. Cell 110: 191-202.
35. Wald, D., J. Qin, Z. Zhao, Y. Qian, M. Naramura, L. Tian, J. Towne, J. E. Sims, G. R. Stark, and X. Li. 2003. SIGIRR, a negative regulator of toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4: 920-927.
36. Liang, J., D. Jiang, J. Griffith, S. Yu, J. Fan, X. Zhao, R. Bucala, and P. W. Noble. 2007. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol. 178: 2469-2475.
37. Wilkinson, T. S., S. Potter-Perigo, C. Tsoi, L. C. Altman, and T. N. Wight. 2004. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 31: 92-99.
38. Yu, W. H., J. F. Woessner, Jr., J. D. McNeish, and I. Stamenkovic. 2002. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16: 307-323.
39. Orian-Rousseau, V., L. Chen, J. P. Sleeman, P. Herrlich, and H. Ponta. 2002. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16: 3074-3086.